We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sean Liu

Sean TH Liu MD, PhD

Assistant Professor of Infectious Diseases at the Icahn School of Medicine at Mount Sinai, New York, NY

Sean Liu is the Medical Director of the COVID Trials Unit at the Icahn School of Medicine at Mount Sinai. Sean earned his PhD at Princeton University studying human cytomegalovirus in the laboratory of Dr. Thomas Shenk. He completed his post-doctoral training at the Icahn School of Medicine at Mount Sinai developing universal influenza vaccine candidates under the guidance of Dr. Peter Palese. He completed his infectious disease fellowship at the Icahn School of Medicine at Mount Sinai. He is an ABIM Board Certified physician in internal medicine and infectious diseases.

Since March 2020, Sean helped to establish the convalescent plasma treatment program at the Mount Sinai Hospital as well as coordinate multiple COVID-19 clinical studies.

Disclosures

Dr. Liu reports no disclosures.